The Latest Cardiac and Vascular News
USHV’s Leadership Team Grows to Strengthen its Mission to Partner with Cardiovascular Physicians Focused on High Quality Care in Support of Long-Term Goals for National Footprint Expansion NASHVILLE, Tenn.–(BUSINESS WIRE)–US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, announced today that Mike Englehart […]
SAN FRANCISCO, Sept. 21, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent and predict disease, will discuss the Company’s strategies for long-term growth, provide an update on its innovation pipeline and share its financial goals […]
DUBLIN, Sept. 21, 2022 /PRNewswire/ — Medtronic plc (the “Company”) ( NYSE: MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ( “Medtronic Luxco”) has closed a registered public offering (the “Offering”) of €500,000,000 principal amount of 2.625% Senior Notes due 2025, €1,000,000,000 principal amount of 3.000% Senior Notes due 2028, €1,000,000,000 […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces that at its virtual Special Meeting of Stockholders held today, the Company’s stockholders approved all three proposals on the proxy filed with the Securities and Exchange Commission on August 29, 2022. The Company also announces that its […]
Globally recognized entrepreneur and medical device developer Manny Villafaña PhD Sc. secures additional financing to accelerate his latest venture. MINNEAPOLIS, Sept. 20, 2022 /PRNewswire/ — Medical 21, a medtech company aiming to transform heart bypass surgery with a revolutionary artificial graft, says it has successfully closed a $20 million commitment pursuant to Regulation D, […]
Lt. General Bruce Green, M.D., USAF-ret. Joins Board of Directors Cindy Cao, Ph.D. Appointed as Chief Regulatory Officer DURHAM, N.C., Sept. 20, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissues, today announced the appointments of two distinguished healthcare professionals […]
Acquisition further strengthens Rocket’s leadership in AAV-based cardiac gene therapy and expands Company’s near-term clinical assets for the treatment of heart conditions Significant unmet medical need in BAG3-associated dilated cardiomyopathy, with meaningful commercial opportunity, comparable to Danon Disease Creates strong synergies by combining key assets, personnel, capabilities and IP, as […]
Internationally recognized physician brings decades of innovative care to the growing group practice. WELLESLEY, Mass.–(BUSINESS WIRE)–The Vascular Care Group, a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is pleased to announce that Dr. Lawrence Garcia has joined the Wellesley center. Lawrence A. Garcia, MD, […]
Miami-based Physician Specializes in Minimally Invasive Treatments for Peripheral Vascular Disease, Cancer, and Other Diseases HINGHAM, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), continuing its recent success of strengthening its Scientific Advisory Board with the recent recruitment of Key Opinion Leaders (KOLs), today announced that […]
DUBLIN, Sept. 15, 2022 /PRNewswire/ — Medtronic plc (the “Company”) ( NYSE:MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. (“Medtronic Luxco”), has priced an offering (the “Offering”) of €500,000,000 principal amount of 2.625% senior notes due 2025, €1,000,000,000 principal amount of 3.000% senior notes due 2028, €1,000,000,000 principal amount of […]
